All News

The Elevate Apical and Posterior Prolapse Repair System (American Medical Systems, Minnetonka, MN) offers anatomic "cure" rates (stage ≤1 prolapse) of 89.2% in patients with apical prolapse and 91.7% in those with posterior vaginal prolapse, according to the results of a 12-month single-arm, prospective multicenter study.

The FDA has approved testosterone topical solution CIII (Axiron) for replacement therapy in men for certain conditions associated with a deficiency or absence of testosterone.

An FDA Oncologic Drugs Advisory Committee has voted against the use of two 5-alpha-reductase inhibitors for reducing the risk of prostate cancer in men at risk for the disease.

Among low-risk prostate cancer patients, active surveillance shows higher measures on quality of life than an initial treatment such as surgery, although the optimal strategy appears highly dependent on individual patient preferences.

In response to the looming reduction in Medicare reimbursement slated to begin Dec. 1, meridianEMR is offering a special "meridianEMR Doc Fix," which includes a 21.9% reduction on all new meridianEMR system orders beginning Nov. 10, 2010 and ending Dec. 31, 2010.

The American Medical Association's House of Delegates unanimously adopted a resolution introduced by The Endocrine Society calling for the standardization of testosterone assays, including increased measures of analytical accuracy by laboratory associations and education for clinicians who use the assays.

A team-based treatment approach to managing prostate and other urologic cancers appears to provide a number of significant benefits, including improved survival, according to the results of two recent studies.

Men treated with androgen deprivation therapy (ADT) for prostate cancer face a 30% to 40% higher risk of colorectal cancer compared with patients who have not received this treatment, say researchers from the University of Michigan, Ann Arbor.

Both houses of Congress have voted to delay for 1 month a 23% reimbursement cut for physicians who treat Medicare patients that was scheduled to take effect Dec. 1.

Send your question to our coding/reimbursement experts Ray Painter, MD, and Mark Painter.

Recent political developments will impact public policy, including redistricting, state budgets, and matters that influence the practice of medicine.

If you're just considering cost effectiveness, not necessarily results, hand-cut mesh repair for anterior vaginal prolapse repair beats mesh kit repair and traditional colporrhaphy.

In patients with refractory urge incontinence, a variety of non-pharmacologic therapeutic options can be used as an alternative or complement to anticholinergic medications. Maximizing conservative measures, namely behavioral therapy and physical therapy, offers multiple benefits and adds little risk for the majority of patients.

Health care reform moved close to the top of urologists' concerns in 2010, but a significant percentage say they don't expect the sweeping legislation to change how they practice-at least not yet.

Urologists need to be mindful of how the patient-centered medical home emerges and how they can effectively work with the model to ensure coordination of care and quality outcomes for patients with chronic urologic conditions.

For several urologists, the concept behind reform was strong, but the logistics of implementing it are daunting.

With a new, Republican-controlled House of Representatives and more GOP votes in the Senate, what are the chances of finally achieving a permanent fix of the Medicare fee schedule that has plagued urologists and every other physician who treats Medicare patients for years?

The experience of one center with vaginal mesh kits for prolapse repair shows that morbidity can be acceptable and patient satisfaction rates high-in the hands of very experienced surgeons.

The newest urology products and services from Ethicon, Inc., Calypso Medical Technologies, Inc., the American College of Surgeons Health Policy Research Institute, Siemens Healthcare, the Turek Clinic, American Medical Systems, the Employers Action Coalition on Healthcare, and Massachusetts General Hospital.

Men with mild to moderate stress incontinence following radical prostatectomy may find relief with a newer-generation male sling.

Urologists have strong opinions about politics and health care reform. About four out of five urologists are extremely or very concerned about declining reimbursement, increasing government regulations, and health care reform regulations.

A structured product is a contract that promises to pay a future amount based on the performance of an underlying asset, such as a stock, market index, or commodity. The payoff is usually linked to a preset formula.

Leonard G. Gomella, MD, co-investigator of the REDUCE trial, discusses what has been learned from three prostate cancer prevention trials and the future of prostate cancer chemoprevention.

Nanoparticle technology shows promise for improving the tissue-ablating efficiency of transurethral microwave therapy for treating BPH.

Urologists choose flexible options when obtaining CME credit.

Transobturator and retropubic mid-urethral sling procedures appear to have equivalent efficacy but show different complications when used for the treatment of female stress urinary incontinence.

This article will help you understand the dynamics of selling your practice and explain how to accomplish this once-in-a-lifetime transaction.

A pilot study evaluating spinal nerve re-routing to restore bladder and bowel function in children with spina bifida has generated some promising results that are a basis for undertaking a larger and more rigorous multicenter trial.

I never joined the transrectal biopsy herd. I stuck with the perineal biopsy, which has been proven in a head-to-head trial to have a better yield of cancer.

Intraspinal nerve rerouting to establish a reflex pathway from skin to spinal cord to bladder is a safe procedure in spinal cord injured patients, but does not allow patients to initiate voluntary micturition.